Due to worsening non-neurologic disease, 4 patients were transitioned from etanercept to a monoclonal antibody against TNF, with a 5th transitioning to a monoclonal antibody following the development of optic neuritis while on etanercept. The gene discussed is TNF; the disease is optic neuritis.